Trials / Completed
CompletedNCT03691831
A Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 502 (actual)
- Sponsor
- Aclaris Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
Phase 3 Study of A-101 Topical Solution in Subjects with Common Warts
Detailed description
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Active | A-101 45% (hydrogen peroxide 45% topical solution) |
| OTHER | Vehicle | Vehicle solution containing isopropyl alcohol and water |
Timeline
- Start date
- 2018-09-13
- Primary completion
- 2019-04-21
- Completion
- 2019-07-09
- First posted
- 2018-10-02
- Last updated
- 2020-10-27
- Results posted
- 2020-10-05
Locations
24 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03691831. Inclusion in this directory is not an endorsement.